Lexology December 6, 2024
Pearce IP

On 6 December 2024, New Zealand’s Pharmac announced that it would, in partnership with AstraZeneca, be providing funding to four more cancer treatments and respiratory medicines including AstraZeneca/Daiichi Sankyo’s Enhertu®...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Investments, Pharma, Pharma / Biotech, Trends
Building Resilience: CDMO Strategies for Drug Supply Chain Stability
Metsera’s IPO Raises $275M to Show How Its Obesity Drugs Can Top Current GLP-1s
How will CMS administer the IRA Medicare Drug Price Negotiation under Trump?
STAT+: How Trump’s tariffs may raise health care costs, from medical devices to prescription drugs
One Institution’s Evidence-Based Approach to Adopting Biosimilars

Share This Article